Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
LBP AM's MRK Position: Q1 2026 in Review
LBP AM reduced its Merck (MRK) stake by 48% in Q1 2026, selling an estimated $20.8M and leaving 196,922 shares worth $23.7M. The position accounts for 0.32% of the portfolio, ranked #60.
LBP AM first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $55.7M in Q4 2023. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- LBP AM held 196,922 shares of Merck worth $23.7M as of Q1 2026.
- LBP AM sold 180,502 Merck shares in Q1 2026, an estimated $20.8M.
- Merck made up 0.32% of LBP AM's portfolio in Q1 2026, its #60 holding.
- LBP AM first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
- LBP AM's Merck position peaked at $55.7M in Q4 2023.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on LBP AM's 13F filing for Q1 2026, filed 27 Apr 2026.